Redirect Notice
The previous page is sending you to
http://www.businesswire.com/news/home/20121108005079/en/Recruitment-complete-Trajenta%C2%AE-linagliptin-cardiovascular-outcome-study
.
If you do not want to visit that page, you can
return to the previous page
.